4basebio PLC (88Q.DE)

EUR 13.0

(0.78%)

Total Assets Summary of 4basebio PLC

  • 4basebio PLC's latest annual total assets in 2023 was 11.92 Million GBP , up 1.99% from previous year.
  • 4basebio PLC's latest quarterly total assets in 2023 FY was 11.92 Million GBP , up 1.99% from previous quarter.
  • 4basebio PLC reported annual total assets of 11.68 Million GBP in 2022, down -20.49% from previous year.
  • 4basebio PLC reported annual total assets of 14.7 Million GBP in 2021, down -17.45% from previous year.
  • 4basebio PLC reported quarterly total assets of 11.92 Million GBP for 2023 FY, up 1.99% from previous quarter.
  • 4basebio PLC reported quarterly total assets of 11.55 Million GBP for 2023 Q2, down -1.14% from previous quarter.

Annual Total Assets Chart of 4basebio PLC (2023 - 2019)

Historical Annual Total Assets of 4basebio PLC (2023 - 2019)

Year Total Assets Total Assets Growth
2023 11.92 Million GBP 1.99%
2022 11.68 Million GBP -20.49%
2021 14.7 Million GBP -17.45%
2020 17.8 Million GBP 1441.9%
2019 1.15 Million GBP 0.0%

Peer Total Assets Comparison of 4basebio PLC

Name Total Assets Total Assets Difference
BioNTech SE 23 Billion EUR 99.948%
CureVac N.V. 788.89 Million EUR 98.489%
Biotest Aktiengesellschaft 1.44 Billion EUR 99.175%
Biotest Aktiengesellschaft 1.44 Billion EUR 99.175%
BRAIN Biotech AG 70.93 Million EUR 83.194%
Formycon AG 890.36 Million EUR 98.661%
Heidelberg Pharma AG 70.35 Million EUR 83.054%
Medigene AG 31.71 Million EUR 62.41%